Skip to main content

Table 4 Primary and secondary endpoints in the perioperative period

From: Evaluation of the effectiveness and safety of preoperative drug elution balloon therapy in patients with elective tumor surgery and coronary heart disease: a retrospective clinical study

 

DEB group(n = 61)

DES group(n = 66)

P value

Primary outcome

 All cause death

-

-

-

 MACE

6(9.8%)

18(27.3%)

0.012

Fatal arrhythmias

4(15.4%)

2(6.3%)

0.482

 MI

7(11.5%)

23(34.8%)

0.002

 TLR

3(4.9%)

5(7.6%)

0.802

Secondary outcomes

 Bleeding events

5(8.2%)

6(9.1%)

0.858

 Venous thrombotic events

16(26.2%)

22(33.3%)

0.382

  1. MACE major adverse cardiac event, MI myocardial infarction, TLR target lesion revascularization
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us